Manufacturers

Accelerating product access: How channel strategy drives success for new product launches

Manufacturers

Case studies: Maximize your brand's visibility

Webinar on-demand - A Panel Discussion on Navigating Medical Devices in Canada

Manufacturers

Emerging biopharma Outlook Therapeutics shares the benefits of Cencora's international commercialization support

Manufacturers

Recap AMCP 2024: Our thought leadership in action

Manufacturers

Analysis paralysis? Build a better commercialization plan with these launch considerations

Manufacturers

Essential guide to cell and gene therapy (CGT)  commercialization

Manufacturers

Best practice strategies for your emerging biopharma field team search

Manufacturers

Leverage enterprise thinking for commercialization progress

Manufacturers

Accelerating global therapeutic impact

Manufacturers

Planning for the World: Q&A With Sandra Anderson, SVP of International Commercialization at Cencora

Manufacturers

Pharma in the field: Barrett's story

Manufacturers

Podcast: The race to develop innovative products and supply chain solutions 

Manufacturers

Work worth doing: Innovative field solutions

Manufacturers

Essential skills for outsourced field solutions teams

Manufacturers

Q&A – How the tendency towards decentralized supply chains has changed in CGT

Manufacturers

Untangle the complexities of launching a biosimilar

Manufacturers

Valuing potential cures: An examination of ICER’s approach to assessing high-impact single and short-term therapies

Manufacturers

First 10 drugs for Medicare price negotiation announced under IRA

Manufacturers

Q&A – Preparing for the EU Joint Clinical Assessment (JCA) process

Manufacturers

Podcast: Collaborative perseverance to bring change to medicine access

Manufacturers

Podcast: Industry led product development in a rapidly changing CGT landscape

Panel explores insights and implications of the game-changing EU JCA

Manufacturers

Changing Channels

Manufacturers

What biopharma companies need to know about annual reverification

Manufacturers

Empower your people and brand with biopharma learning solutions

Manufacturers

On-demand webinar: The EU JCA process: Opportunities and challenges in bringing innovative medicines to patients in Europe

Manufacturers

Drug development checklist: What to look for in a commercialization partner

Manufacturers

Pre-launch checklist: What to look for in a commercialization partner

Manufacturers

Post-launch checklist: What to look for in a commercialization partner

Reimbursement considerations for home infusions

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Manufacturers

Recap AMCP 2023: Our thought leadership in action

Manufacturers

How to forge stronger working relationships with payers

Manufacturers

Yes, you can commercialize on your own—even if you're an emerging biopharma

Manufacturers

Answering four key questions about HTA market archetypes

Manufacturers

HTA Quarterly | Spring 2023

Manufacturers

The essential guide to drug commercialization

Manufacturers

Three questions biopharma companies must ask when building a cell and gene commercialization strategy

Manufacturers

In conversation with TrakCel: Why successful partnerships can help accelerate advanced therapies

Manufacturers

Interview: Increasing advanced therapies’ connectivity and speed to market through partnership

Manufacturers

Education: The centerpiece of biosimilar adoption

Manufacturers

New pan-EU HTA: How can biopharma navigate the joint clinical assessment?

Manufacturers

Uncommon commonalities: A patient-centric strategy for improving medication adherence

Manufacturers

HTA Quarterly | Summer 2023

Manufacturers

HTA Quarterly | Winter 2022

Manufacturers

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

Manufacturers

On-demand webinar: You’ve created a good patient support program, now make it great

Manufacturers

Closing the gaps in pre-approval information exchange to accelerate product success and patient access

Manufacturers

Answering the challenges of rare disease market access with HEOR

Manufacturers

What to consider when building a channel strategy for a rare disease product

Manufacturers

Alternate payer engagement models are changing the landscape

Manufacturers

5 steps to improved medication adherence

Manufacturers

Culture, people, and an investment in innovation set AmerisourceBergen apart

Manufacturers

Why FormularyDecisions® is the right choice for enterprise biopharma payer engagement 

Manufacturers

Getting the right drug to the right patient at the right place at the right time

Manufacturers

Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies

Manufacturers

How to reach customers in the new world of work

Manufacturers

How to reach customers in the new world of work

Manufacturers

Nine questions about rare and orphan drug commercialization

Manufacturers

Commercializing cell and gene therapies in Canada

Manufacturers

How to optimize the commercial supply chain for cell and gene therapies

Manufacturers

Patient-forward copay solutions: Three considerations for building effective support

Manufacturers

Finding flexibility: Five important features of pharmacy eBV solutions

Telehealth through the lens of value-based care in the US

Manufacturers

Case study: Improving therapy initiation with an AI-guided patient support program

Manufacturers

Webinar: Rethink your commercialization strategy

Manufacturers

Webinar: Key insights on the clinical to commercial transition for autologous therapies

Manufacturers

Building your field reimbursement and access team: The translational experience and skills that matter most

Manufacturers

Work worth doing: Patient support services

Manufacturers

eBook: Bringing innovation to market with digital therapeutics

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

Manufacturers

Digital innovation in patient support

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

Affordability is about more than drug prices

Manufacturers

What manufacturers need to know about reimbursement and patient support for cell and gene therapies

Manufacturers

Navigating the payer landscape for digital therapeutics

Manufacturers

Patient support for digital therapeutics: Do's and don'ts for designing your program

Manufacturers

Digital therapeutics: Critical elements for building effective patient support programs

Manufacturers

Work worth doing: FormularyDecisions

Manufacturers

eBook: Making an impact on medication adherence

Manufacturers

Podcast: ThinkLive Commercialization 2021

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

Manufacturers

What is a digital companion, and how is it changing patient support for the better?

Manufacturers

On-demand webinar: Accelerating access to therapy (a view from the front lines)

Manufacturers

Case study: Improving medication adherence with a digital companion

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Manufacturers

Five questions to ask a potential patient support partner

Manufacturers

The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2

Manufacturers

On-demand webinar: The power of data across your product journey

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

Manufacturers

How to make the most of integrated commercialization solutions

Manufacturers

Buy-and-bill vs. self-administered: Field services remove barriers across access points

Manufacturers

Strategies for addressing copay accumulators: What manufacturers need to know

Manufacturers

Checklist: Four things to look for in a field services partner

Manufacturers

How to maximize your drug commercialization investments

Manufacturers

Launching field services in the midst of COVID-19

Manufacturers

Pharma in the field: Heather's story

Manufacturers

Cell and gene therapies: bringing innovation to market

Manufacturers

Webinar: the growing utilization of copay accumulator programs

Whitepaper: Key Strategies for Cell and Gene Therapy in China

Manufacturers

Pharma in the field: Ashley's story

Manufacturers

Pharma in the field: Tierra's story

Manufacturers

Ebook: Virtual drug commercialization

Manufacturers

The road to a COVID-19 treatment launch

Manufacturers

PAP 2020 panel recap: Navigating COVID-19

Manufacturers

Five growth drivers for the consumer healthcare products market

Manufacturers

Is your PIE incomplete?

Case study: Gaining payer attention through digital innovation

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

Manufacturers

What a unified approach to business excellence means for patient support program success

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

Manufacturers

Webinar Part 2: Leveraging AI within eBV to speed access to therapy

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Manufacturers

Webinar: Patient Assistance in the Wake of COVID19

Manufacturers

Simplifying the Path to Better Patient Outcomes

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Manufacturers

Building Partnerships and Scaling Services to Patient Needs

Manufacturers

A Patient-Centric Approach to Technology and Analytics

Data Analytics Enables Program Improvements for Faster Access to Therapy

Manufacturers

Physician Q&A: How to Boost Confidence in Biosimilars

Manufacturers

Video: Removing Barriers for Biosimilars

Manufacturers

Mind the (Evidence) Gap

Manufacturers

Nurse Stories: Jessica

Manufacturers

Case study: real-world benefits of an oncology navigation program

Manufacturers

White paper: beyond the promise of artificial intelligence in electronic benefit verification

Manufacturers

Infographic: Physician Perspectives on Biosimilars

Manufacturers

InnomarLive 2019: Commercializing in Canada

E-book: Delivering innovation, improving lives

Manufacturers

Nurse Stories: Amy

Manufacturers

How to Launch a Patient Support Program

Manufacturers

How Patient Support Program Nurses Help Break Down Adherence Barriers

Manufacturers

Biosimilars: Market Insights and Growth Factors

Manufacturers

Biosimilars: Launch Insights From the Field

Manufacturers

Biosimilars: Shaping a Moving Market

Manufacturers

Case Study: Improving Speed to Therapy With Provider Portals

Manufacturers

Uncommon Commonalities: A Patient-Centric Strategy for Improving Medication Adherence

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

Manufacturers

How Tech-Enabled Solutions Impact Adherence

Manufacturers

Managing the Growing Expansion of Copay Accumulators

Manufacturers

The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part Two

Manufacturers

The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part One

Manufacturers

The Supply Chain Redefined: Cell and Gene Therapies

Manufacturers

Financial Management for Cell and Gene Therapies

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Manufacturers

Rethink: Channel Strategy for Oral Oncolytics

Infographic: The Road to Commercialization in Canada

Manufacturers

A New Approach to Channel Strategy for Oncology Therapies

Manufacturers

Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Manufacturers

Rethinking Reimbursement and Patient Support Following Medical Innovation

Manufacturers

Information Exchange With Payers and Providers

Manufacturers

The Growth of Biosimilars in the Oncology Pipeline

Manufacturers

Rethink: The Future of Benefit Verification

Manufacturers

Logistics Decisions Will Impact the Success of New Cell and Gene Therapies

Manufacturers

Commercializing Cell and Gene Therapies

Manufacturers

The Fundamentals of Commercialization Strategy